Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 28, 2017 - Issue 4
Submit an article Journal homepage
449
Views
8
CrossRef citations to date
0
Altmetric
Acne

The weeks and the cumulative doses of the first adverse events related to oral isotretinoin in acne patients: analysis of 300 patients

Duriye Deniz DemirserenDepartment of Dermatology, Ataturk Training and Research Hospital, Ankara, Turkey; Correspondence[email protected]
,
Fadime KilincDepartment of Dermatology, Ataturk Training and Research Hospital, Ankara, Turkey;
,
Selma EmreDepartment of Dermatology, Ataturk Training and Research Hospital, Ankara, Turkey;
,
Mesut AkyolBiostatistics and Medical Informatic, Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey
,
Ahmet MetinDepartment of Dermatology, Ataturk Training and Research Hospital, Ankara, Turkey;
&
Akin AktasDepartment of Dermatology, Ataturk Training and Research Hospital, Ankara, Turkey;
Pages 309-313 | Received 13 Apr 2016, Accepted 28 Jul 2016, Published online: 15 Sep 2016

References

  • Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf. 2004;3:119–29.
  • Karadag AS, Kalkan G, Lin YT, Chen WC. Update of oral ısotretinoin in acne treatment. World Clin Dermatol. 2013;1:143–74.
  • Borghi A, Mantovani L, Minghetti S, et al. Acute acne flare following isotretinoin administration: potential protective role of low starting dose. Dermatology (Basel). 2009;218:178–80.
  • Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial. Indian J Dermatol Venereol Leprol. 2011;77:688–94.
  • Lee JW, Yoo KH, Park KY, et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol. 2011;164:1369–75.
  • Rao PK, Bhat RM, Nandakishore B, et al. Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris. Indian J Dermatol. 2014;59:316.
  • Rademaker M. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us? Australas J Dermatol. 2013;54:157–62.
  • Karadag AS, Calka O, Akdeniz N. Evaluation of side effects of Isotretinoin in 150 patients with acne vulgaris. Turkderm. 2011;45:37–42.
  • On SC, Zeichner J. Isotretinoin updates. Dermatol Ther. 2013;26:377–89.
  • Goodfield MJ, Cox NH, Bowser A, et. al. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. Br J Dermatol. 2010;162:1172–9.
  • Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1:162–9.
  • Rademaker M. Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol. 2010;1:248–53.
  • Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg. 2000;4:66–70.
  • Yilmaz Tasdelen O, Yurdakul FG, Duran S, Bodur H. Isotretinoin-induced arthritis mimicking both rheumatoid arthritis and axial spondyloarthritis. Int J Rheum Dis. 2015;18:466–9.
  • Arman A, Demirseren DD, Akoglu G. Tolerance to systemic isotretinoin therapy in two patients using highly wettable contact lenses. Case Rep Ophthalmol Med. 2014;2014:452462.
  • Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19:272–9.
  • Teo K, Yazdabadi A. Isotretinoin and night blindness. Australas J Dermatol. 2014;55:222–4.
  • Chivot M. [Acne flare-up and deterioration with oral isotretinoin]. Ann Dermatol Venereol. 2001;128:224–8.
  • Ahmad HM. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin. Dermatol Ther. 2015;28:151–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.